Netherlands· NL-60b917175377
Xofluza 2 mg/ml, granulaat voor orale suspensie
A other antivirals product containing baloxavir marboxil, registered in Netherlands by Roche Registration GmbH. The same ATC class is registered in 4 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Baloxavir marboxil is registered in 4 of 19 countries.
Countries holding a registration under ATC J05AX (other antivirals), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 1 of them publish a price we can compare per daily dose
Baloxavir marboxil · ATC J05AX
4 / 19 countries
- Canada
- Ireland
- Netherlands
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BALOXAVIR MARBOXIL
- Manufacturer
- Roche Registration GmbH
- Country
- Netherlands (NL)
- ATC code
- J05AX
- ATC class
- Other antivirals
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/20/1500
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Baloxavir marboxil in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumXofluza 2 mg/mlRoche Registration
- CzechiaXOFLUZARoche Registration GmbH, Grenzach-Wyhlen
- IrelandXofluza 2 mg/mL granules for oral suspensionRoche Registration GmbH
- IcelandXofluzaRoche Registration GmbH*
- SwedenXofluza 2 mg/ml Granulat till oral suspensionRoche Registration GmbH
- SwitzerlandXofluza 10 mg, Granulat zur Herstellung einer Suspension zum Einnehmen (Beutel)Roche Pharma (Schweiz) AG
- FinlandXofluzaRoche Registration GmbH
- United StatesXofluzaSportpharm LLC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Xofluza
- Liechtenstein · Xofluza
- Norway · Xofluza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/886036f3-8303-4545-9793-417d97245918 GET /v1/drugs/886036f3-8303-4545-9793-417d97245918?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granulaat voor orale suspensie",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/xofluza-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Other Antivirals",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp129329",
"excipients": [
"AARDBEIENSMAAKSTOF",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"MALTITOL (E 965)",
"MANNITOL (D-) (E 421)",
"NATRIUMCHLORIDE",
"POVIDON K 25 (E 1201)",
"PROPYLEENGLYCOL (E 1520)",
"SILICIUMDIOXIDE (E 551)",
"SUCRALOSE (E 955)",
"TALK (E 553b)"
],
"substances": [
"BALOXAVIR MARBOXIL"
],
"leaflet_url": null,
"authorised_at": "2021/01/07",
"procedure_number": "EMEA/H/C/004974",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/20/1500",
"additional_monitoring": "N"
}See everything about baloxavir marboxil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.